Enzo Biochem Inc
(ENZB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 07/31
| 01-2004 | 10-2003 | 07-2003 | 04-2003 | 01-2003 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,779 | -323 | 3,844 | 6,367 | 5,134 |
| Depreciation Amortization | 1,105 | 467 | 1,808 | 1,409 | 954 |
| Income taxes - deferred | -1,608 | -321 | -128 | N/A | N/A |
| Accounts receivable | -5,311 | -1,749 | -6,344 | -4,052 | -4,045 |
| Other Working Capital | -6,580 | -1,800 | -2,810 | -1,161 | -858 |
| Other Operating Activity | 10,982 | 4,063 | 15,737 | 10,337 | 8,145 |
| Operating Cash Flow | $-3,191 | $337 | $12,106 | $12,900 | $9,330 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -193 | -96 | -15,293 | N/A | N/A |
| PPE Investments | -560 | -295 | -957 | -636 | -402 |
| Purchase Sale Intangibles | -43 | -43 | -354 | -300 | -149 |
| Other Investing Activity | -39 | -47 | -354 | -306 | -151 |
| Investing Cash Flow | $-792 | $-438 | $-16,604 | $-942 | $-553 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 521 | 279 | 631 | 23 | 23 |
| Financing Cash Flow | $521 | $279 | $631 | $23 | $23 |
| Beginning Cash Position | 63,268 | 63,268 | 67,135 | 67,135 | 67,135 |
| End Cash Position | 59,806 | 63,446 | 63,268 | 79,116 | 75,935 |
| Net Cash Flow | $-3,462 | $178 | $-3,867 | $11,981 | $8,800 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,191 | 337 | 12,106 | 12,900 | 9,330 |
| Capital Expenditure | -560 | -295 | -957 | -636 | -402 |
| Free Cash Flow | -3,751 | 42 | 11,149 | 12,264 | 8,928 |